Sandra Aramburo and Anthony López join the Board of Automation & Validation Solutions (AVS)

AVS is a global full-service company that focuses on quality management, regulatory compliance, and engineering services. AVS’s mission is to provide innovative solutions to the pharmaceutical, biotech, medical device, and diagnostic industries from concept to care. In May 2022, Altura Capital acquired a majority interest in the company.

Anthony López, an experienced C-Suite and Board executive, and Sandra Aramburo, a seasoned Board executive with 25 years of experience in the pharmaceutical and consumer industry, will play a key leadership role in the growth of AVS.

“Altura Capital has a unique strategy to grow portfolio companies. We have a solid governance and value creation framework that helps overlooked and undercapitalized companies grow. The Altura Executive Operating Partners provide industry expertise and strategic vision to increase the topline and strengthen corporate relations”, said Monika Mantilla Co-Founder and CEO of Altura Capital.

Sandra Aramburo has held leadership roles at companies like Sanofi, Merck, Schering Plough, and Bayer, being the General Manager of Sanofi Vaccines for 26 countries in Latam. She brings solid and proven experience in commercial strategy definition, establishing solid cultural organizations, incorporating innovation and transformation, mobilizing teamwork with a transcendent purpose within an ethical framework, and leveraging diversity as a driver of innovation, ensuring profitable growth. Sandra served as the Global Leader of the ERG (employee resource group) for Gender at Sanofi and as a founding member of Mpodera, a non-profit movement to support women’s professional growth in the Health Sector.

Anthony López has a strong track record of success in global leadership positions, including a $1Billion P&L responsibility. He is recognized as a strategic thinker and leadership talent developer with a proven record for catalyzing positive impact and empowering change while driving breakthrough results. Anthony is a sought-after speaker and expert on leadership, executive coach, and is the author of “The Legacy Leader, “Breakthrough Thinking”, “The Leader’s Lobotomy”, “The Leader In the Mirror”, and “LEGACYWOMAN: The Legacy Leader As Superhero”.

“We are thrilled to welcome Sandra and Anthony to the AVS Life Sciences family! With their extensive and diverse experience in growing life sciences quality, regulatory and validation services, they are a perfect fit for our organization. We look forward to the incredible contributions they will bring to our mission of advancing life sciences and improving lives,” said Ruben Dario Taborda, CEO of AVS Life Sciences.